DNA repair pathways in drug resistance in melanoma

Penny A Bradbury1, Mark R Middleton

  • 1Cancer Research UK Medical Oncology Unit, Churchill Hospital, Oxford, UK.

Anti-Cancer Drugs
|May 29, 2004
PubMed

Insights

Metastatic melanoma is hard to treat due to drug resistance. Understanding cellular pathways involved in chemotherapy resistance may reveal new therapeutic targets for this deadly cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Metastatic melanoma presents a significant clinical challenge with a poor prognosis.
  • Current treatments like dacarbazine and cisplatin are often ineffective due to inherent drug resistance in melanoma cells.

Purpose of the Study:

  • To explore the molecular mechanisms underlying chemotherapy resistance in metastatic melanoma.
  • To identify novel therapeutic targets for improving treatment outcomes in advanced melanoma.

Main Methods:

  • Review of existing literature on melanoma chemoresistance.
  • Analysis of cellular pathways involved in DNA damage recognition, repair, and apoptosis.
  • Investigation of intrinsic and acquired resistance mechanisms.

Main Results:

  • Melanoma exhibits substantial resistance to DNA-damaging chemotherapies.
  • Multiple cellular pathways contribute to both intrinsic and acquired drug resistance.
  • Understanding these resistance pathways is crucial for therapeutic development.

Conclusions:

  • Chemotherapy resistance is a major obstacle in treating metastatic melanoma.
  • Further research into cellular resistance mechanisms can uncover novel therapeutic strategies.
  • Targeting these pathways holds promise for advancing melanoma treatment.

Related Concept Videos

Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...